Tender detail
Conclusion of non-exclusive rebate agreements for medicines containing etanercept under an open-house model
Summary
The procurement concerns non-exclusive rebate agreements for medicines containing etanercept under an open-house model. Suppliers receive no exclusivity, and purchase quantities depend on demand and are not guaranteed. The agreements end no later than 30 June 2028, although the procedure may be terminated earlier.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.